Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAGLA | Q9Y4D2 | 15/20 | 0.52 |
| ▸ | FAAH | O00519 | 9/20 | 0.52 |
| ▸ | CES1 | P23141 | 6/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | XDH | P47989 | 1/20 | 0.37 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6062834 | 0.88 | DAGLA (0.56) | DAGLAFAAHCES1ALDH1A1 | |
| SCHEMBL6630904 | 0.86 | DAGLA (0.46) | DAGLAFAAHCES1ALDH1A1 | |
| SCHEMBL6631047 | 0.86 | DAGLA (0.52) | DAGLAFAAHCES1ALDH1A1XDH | |
| SCHEMBL6061806 | 0.86 | DAGLA (0.48) | DAGLAFAAHCES1 | |
| SCHEMBL6632372 | 0.85 | PTPN1 (0.37) | DAGLAFAAHCES1ALDH1A1MTNR1A | |
| SCHEMBL6630749 | 0.84 | DAGLA (0.53) | DAGLAFAAHCES1ALDH1A1XDH | |
| SCHEMBL6061821 | 0.83 | DAGLA (0.51) | DAGLAFAAHCES1ALDH1A1 | |
| SCHEMBL6061613 | 0.83 | DAGLA (0.51) | DAGLAFAAHCES1ALDH1A1 | |
| SCHEMBL6061646 | 0.83 | DAGLA (0.48) | DAGLAFAAHCES1ALDH1A1 | |
| SCHEMBL6061783 | 0.83 | DAGLA (0.47) | DAGLAFAAHCES1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1397340-A2 | CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2004-03-17 | — | — | EP | claimed |
| WO-2002098850-A2 | CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2002-12-12 | — | — | WO | claimed |
| EP-1694357-A1 | USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC | AXYS PHARMACEUTICALS, INC. (US) | 2006-08-30 | — | — | EP | disclosed |
| WO-2005058348-A1 | USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC | AXYS PHARMACEUTICALS, INC. (US) | 2005-06-30 | — | — | WO | disclosed |
| EP-1397340-A2 | CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2004-03-17 | — | — | EP | disclosed |
| WO-2002098850-A2 | CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2002-12-12 | — | — | WO | disclosed |